Physiological calcium-dependent neuromuscular transmission

Physiological calcium-dependent neuromuscular transmission is the fundamental biological process by which a motor neuron signal is converted into skeletal muscle contraction (StatPearls, 2023). This process begins when an action potential reaches the presynaptic terminal, triggering the opening of voltage-gated calcium channels, specifically the P/Q-type (NCBI, 2022). The resulting influx of calcium ions promotes the fusion of acetylcholine-containing vesicles with the presynaptic membrane via SNARE proteins, leading to the exocytosis of acetylcholine (ACh) into the synaptic cleft (PubMed, 2021). ACh then diffuses across the cleft and binds to nicotinic acetylcholine receptors (nAChR) on the postsynaptic muscle membrane, causing depolarization and subsequent muscle contraction (StatPearls, 2023). This transmission pathway is the site of action for numerous pharmacological agents, including acetylcholinesterase inhibitors used to treat Myasthenia Gravis and neuromuscular blocking agents used in anesthesia (PubChem, 2024). Dysfunction in this process, often due to autoimmune attacks on nAChRs or calcium channels, leads to clinical conditions such as Myasthenia Gravis and Lambert-Eaton myasthenic syndrome (NINDS, 2023). Additionally, toxins such as botulinum toxin can disrupt this process by inhibiting the calcium-dependent release of neurotransmitters, resulting in paralysis (StatPearls, 2023).

Other names

Neuromuscular transmissionSynaptic transmission at the neuromuscular junctionNMJ transmissionExcitation-contraction coupling

Inhibition of acetylcholinesterase, competitive antagonism of nicotinic acetylcholine receptors, blockade of presynaptic potassium channels to enhance calcium influx, or proteolytic cleavage of SNARE proteins to inhibit vesicle fusion.